Literature DB >> 24052422

Circulating cytokines and gastric cancer risk.

Meira Epplein1, Yong-Bing Xiang, Qiuyin Cai, Richard M Peek, Honglan Li, Pelayo Correa, Jing Gao, Jie Wu, Angelika Michel, Michael Pawlita, Wei Zheng, Xiao-Ou Shu.   

Abstract

PURPOSE: Chronic inflammation has been hypothesized to play a significant role in the aetiology of cancer, including gastric cancer. In the present study, we sought to examine pre-diagnostic systemic cytokine levels in plasma, which can be seen as markers of aggregate inflammation, and risk of distal gastric cancer in a case-control study nested within the prospective Shanghai Men's Health Study.
METHODS: Circulating levels of eight inflammation-related cytokines were measured in the plasma collected at baseline for 180 incident cases of distal gastric cancer and 358 matched controls. Helicobacter pylori sero-positivity was assessed using multiplex serology. Conditional logistic regression was used to calculate odds ratios (ORs) and 95 % confidence intervals (CI).
RESULTS: Individuals with IL-8 levels above the lowest quartile were at twofold increased odds of gastric cancer [OR 1.91 (95 % CI 1.05-3.46), OR 2.10 (95 % CI 1.19-3.74), and OR 2.30 (95 % CI 1.26-4.19), for the second through fourth quartiles, respectively]. While there were suggestions of an increase in risk with increased level of many of the other cytokines measured (IL-1β, IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ), no significant associations were found at the p < 0.05 level. Infection with CagA-positive H. pylori did not modify these associations.
CONCLUSIONS: In a population with high gastric cancer incidence and high H. pylori prevalence, increased circulating levels of IL-8 may indicate increased risk of gastric cancer. These findings add to our understanding of the disease and further efforts to uncover biomarkers of disease risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24052422      PMCID: PMC3828746          DOI: 10.1007/s10552-013-0284-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  23 in total

1.  Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer.

Authors:  A Macrì; A Versaci; S Loddo; G Scuderi; M Travagliante; G Trimarchi; D Teti; C Famulari
Journal:  Biomarkers       Date:  2006 Mar-Apr       Impact factor: 2.658

2.  Helicobacter pylori multiplex serology.

Authors:  Angelika Michel; Tim Waterboer; Manfred Kist; Michael Pawlita
Journal:  Helicobacter       Date:  2009-12       Impact factor: 5.753

Review 3.  Inflammation, microenvironment, and the immune system in cancer progression.

Authors:  Andrew Keibel; Vinod Singh; Mahesh C Sharma
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

4.  Prevalence of obesity and correlations with lifestyle and dietary factors in Chinese men.

Authors:  Sang-Ah Lee; Wanqing Wen; Wang Hong Xu; Wei Zheng; Honglan Li; Gong Yang; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Obesity (Silver Spring)       Date:  2008-03-20       Impact factor: 5.002

Review 5.  How the study of Helicobacter infection can contribute to the understanding of carcinoma development.

Authors:  C Stoicov; H Li; J Cerny; J M Houghton
Journal:  Clin Microbiol Infect       Date:  2009-09       Impact factor: 8.067

6.  Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies.

Authors:  Sang-Ah Lee; Asha Kallianpur; Yong-Bing Xiang; Wanqing Wen; Qiuyin Cai; Dake Liu; Sergio Fazio; MacRae F Linton; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

7.  Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.

Authors:  Meira Epplein; Abraham M Y Nomura; Lynne R Wilkens; Brian E Henderson; Laurence N Kolonel
Journal:  Am J Epidemiol       Date:  2009-07-07       Impact factor: 4.897

8.  Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study.

Authors:  Hui Cai; Wei Zheng; Yong-Bing Xiang; Wang Hong Xu; Gong Yang; Honglan Li; Xiao Ou Shu
Journal:  Br J Nutr       Date:  2007-05-25       Impact factor: 3.718

Review 9.  Cytokine polymorphisms and gastric cancer risk: an evolving view.

Authors:  Barbara G Schneider; M Constanza Camargo; Kelli K Ryckman; Liviu A Sicinschi; M Blanca Piazuelo; Jovanny Zabaleta; Pelayo Correa; Scott M Williams
Journal:  Cancer Biol Ther       Date:  2007-11-05       Impact factor: 4.742

10.  Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.

Authors:  C C Abnet; N D Freedman; F Kamangar; M F Leitzmann; A R Hollenbeck; A Schatzkin
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

View more
  18 in total

1.  Relationship between serum inflammatory cytokines and lifestyle factors in gastric cancer.

Authors:  Xian Sun; Chun-Jie Xiang; Juan Wu; Wei Dong; Zhen Zhan; Rui-Ping Wang; Jun-Feng Zhang
Journal:  Mol Clin Oncol       Date:  2019-01-22

2.  Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patients.

Authors:  Jie Chen; Ye Zhou; Yu Xu; Hui-Yan Zhu; Ying-Qiang Shi
Journal:  Tumour Biol       Date:  2015-10-18

3.  Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.

Authors:  Danielle M Carrick; Anil K Chaturvedi; Meredith S Shiels; Rao L Divi; Kelly K Filipski; Elizabeth F Hebert; Mukesh Verma; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-24       Impact factor: 4.254

4.  Preferential Tim-3 expression on Treg and CD8(+) T cells, supported by tumor-associated macrophages, is associated with worse prognosis in gastric cancer.

Authors:  Pinying Shen; Rongxi Yue; Jiahong Tang; Haige Si; Liqun Shen; Changsheng Guo; Lixin Zhang; Huaizhong Han; Haihan K Song; Pengfei Zhao; Ning Wang; Zongchang Song; Chunliang Guo
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

5.  Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.

Authors:  Chan-Young Ock; Ah-Rong Nam; Ju-Hee Bang; Tae-Yong Kim; Kyung-Hun Lee; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Do-Youn Oh
Journal:  Gastric Cancer       Date:  2015-12-17       Impact factor: 7.370

6.  Complement receptor 1 genetic variants contribute to the susceptibility to gastric cancer in chinese population.

Authors:  Lina Zhao; Zhi Zhang; Jia Lin; Lei Cao; Bing He; Sugui Han; Xuemei Zhang
Journal:  J Cancer       Date:  2015-04-05       Impact factor: 4.207

7.  Association between obesity and biomarkers of inflammation and metabolism with cancer mortality in a prospective cohort study.

Authors:  Daniel T Dibaba; Suzanne E Judd; Susan C Gilchrist; Mary Cushman; Maria Pisu; Monika Safford; Tomi Akinyemiju
Journal:  Metabolism       Date:  2019-02-23       Impact factor: 8.694

8.  The association of lymphotoxin-beta receptor with the subsequent diagnosis of incident gastrointestinal cancer: results from the Dallas Heart Study.

Authors:  Colin P Bergstrom; Muhammad S Beg; Colby Ayers; Arjun Gupta; Ian J Neeland
Journal:  J Gastrointest Oncol       Date:  2020-02

9.  Circulating immune- and inflammation-related biomarkers and early-stage noncardia gastric cancer risk.

Authors:  Minkyo Song; Charles S Rabkin; Hidemi Ito; Isao Oze; Yuriko N Koyanagi; Ruth M Pfeiffer; Yumiko Kasugai; Keitaro Matsuo; M Constanza Camargo
Journal:  Eur J Cancer Prev       Date:  2022-05-01       Impact factor: 2.164

10.  Regulatory B Cell Function Is Suppressed by Smoking and Obesity in H. pylori-Infected Subjects and Is Correlated with Elevated Risk of Gastric Cancer.

Authors:  Guanggang Li; Hasi Wulan; Zongchang Song; Paul A Paik; Ming L Tsao; Gary M Goodman; Paul T MacEachern; Robert S Downey; Anna J Jankowska; Yaron M Rabinowitz; Thomas B Learch; David Z Song; Ji J Yuan; Shihang Zheng; Zhendong Zheng
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.